TITLE

Regression of Barrett esophagus using high dose proton pump inhibitor

AUTHOR(S)
Barrett, Kurt A
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS1
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article " Regression of Barrett Esophagus Using High Dose Proton Pump Inhibitor," by Kurt A. Barrett is presented.
ACCESSION #
66954570

 

Related Articles

  • Association between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study. Jiro Watari; Kazutoshi Hori; Fumihiko Toyoshima; Noriko Kamiya; Takahisa Yamasaki; Takuya Okugawa; Haruki Asano; Zhao Liang Li; Takashi Kondo; Hisatomo Ikehara; Jun Sakurai; Toshihiko Tomita; Tadayuki Oshima; Hirokazu Fukui; Hiroto Miwa // BMC Gastroenterology;2013, Vol. 13 Issue 1, p1 

    Background: The association between obesity and Barrett's esophagus (BE) in the Japanese population remains unclear. The prevalence of BE and its associated risk factors was examined. Methods: A cross-sectional study of 1581 consecutive individuals who underwent upper gastrointestinal endoscopy...

  • Prevention of Barrett's metaplasia in a human model of duodenogastro-oesophageal reflux. Cade, Richard J.; Fox, Adrian M.; Fahy, Eamonn T.; Hii, Michael W. // Gastroenterology Insights;2013, Vol. 5 Issue 1, p12 

    The development of Barrett's esophagus above the anastomosis following esophagogastrectomy has been reported in several studies. In this prospective study we set out to examine the prevalence of this phenomenon in a group of patients who have been strictly adherent to post operative proton pump...

  • Priming the Pump of a Leaky Gut. Robinson, Malcolm // Internal Medicine Alert;3/15/2009, Vol. 31 Issue 5, p35 

    The article reports on the study regarding the effect of Proton Pump Inhibitors (PPIs) on the leakiness found in upper gastrointestinal (GI) mucosa. It states that PPI is one of the most widely used drug classes in the U.S. It notes that PPIs therapy might improve the leakiness in GI mucosa in...

  • What's Hot in the Red Journal This Month.  // American Journal of Gastroenterology;Jul2011, Vol. 106 Issue 7, p1179 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the observational studies to determine risk of fracture with the use of proton pump inhibitors (PPIs), combining non-invasive fibrosis tests to develop accurate fibrosis...

  • Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea. Hyun Jin Jo; Hye Seung Lee; Nayoung Kim; Ryoung Hee Nam; Hyun Chang; Min Soo Kim; Sung Eun Kim; Jane C. Oh; Dong Ho Lee; Hyun Chae Jung // Journal of Neurogastroenterology & Motility;Apr2013, Vol. 19 Issue 2, p210 

    Background/Aims: There has been no report regarding the regression of Barrett's esophagus (BE) by continuous treatment of proton pump inhibitor (PPI). The aim of this study was to determine the regression rate of BE by PPI and predictable markers related to regression. Methods: Thirty-five...

  • PPIs cost effective in Barrett's oesophagus.  // PharmacoEconomics & Outcomes News;May2014, Vol. 703 Issue 1, p7 

    The article discusses research by R. Z. Sharaiha and colleagues, published in the periodical "Digestive Diseases and Science" on the cost-effectiveness of using chemoprevention with proton pump inhibitors in Barrett's esophagus.

  • Barrett's guidelines update includes screening, surveillance, management.  // Geriatrics;May2008, Vol. 63 Issue 5, p21 

    The article reports on the new guidelines for diagnosing and treating Barrett's esophagus published by the American College for Gastroenterology. According to the guidelines, patients with low-grade dysplasia need follow-up endoscopy within 6 months and those with high-grade dysplasia within...

  • Proton Pump Inhibitors in Pediatrics: Evaluation of Efficacy in GERD Therapy. Romano, Claudio; Chiaro, Andrea; Comito, Donatella; Loddo, Italia; Ferra�, Valeria // Current Clinical Pharmacology;Feb2011, Vol. 6 Issue 1, p41 

    Gastroesophageal reflux (GER) is defined as the passage of gastric contents into the esophagus. It occurs in healthy infants and can be considered physiological process. Uncomplicated GER can present with recurrent vomiting or regurgitation without any other symptoms and is usually managed by...

  • Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Fairé, R.; van Malenstein, H.; De Vos, A.; Geboes, K.; Depoortere, I.; Vanden Berghe, P.; Fornari, F.; Blondeau, K.; Mertens, V.; Tack, J.; Sifrim, D. // Gut;Oct2008, Vol. 57 Issue 10, p1366 

    Background: Severe duodeno-gastro-oesophageal reflux (ODOR) is a risk factor for oesophagitis and Barrett's oesophagus. Patients with non-erosive reflux disease (NERD) have a slight increase in DOOR. Patients with gastro-oesophageal reflux disease (GORD), who are taking proton pump inhibitors...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics